Lörrach, Germany

Detlef Eisenkrätzer


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Detlef Eisenkrätzer: Glycosylation Breakthroughs

Introduction: Detlef Eisenkrätzer, based in Lörrach, Germany, is an accomplished inventor known for his significant contributions to the field of glycosylation. With a focus on enhancing the use of human polypeptide N-acetylgalactosaminytransferase T-4 (GalNAc-T4), Detlef has made strides in developing methods that are crucial for biotechnology and pharmaceutical applications.

Latest Patents: Detlef Eisenkrätzer holds a patent for "Glycosylation using GalNac-T4 transferase." This patent discloses the innovative use of GalNAc-T4 in glycosylating substrates, complementing the activities of other enzymes such as GalNAc-T1, -T2, and -T3. The applications of these glycosylated substrates are particularly promising in the preparation of vaccines and anti-inflammatory agents. Moreover, Detlef's patent also includes a method for producing the soluble form of the GalNAc-T4 enzyme, further enhancing its applicability in various therapeutic contexts.

Career Highlights: Throughout his career at Glycozym Aps, Detlef has demonstrated a commitment to advancing glycosylation methods, contributing to both scientific understanding and practical applications of enzymatic processes in medicine. His work aligns with the ongoing efforts to improve vaccine efficacy and develop new treatment modalities.

Collaborations: Detlef Eisenkrätzer collaborates closely with esteemed professionals in the field, including Frau Helle Hassan and Henrik Clausen. Together, they work on innovative projects that push the boundaries of glycosylation technology and its implications for healthcare.

Conclusion: Detlef Eisenkrätzer continues to make an impact in the realm of glycosylation and biotechnology. His patent and collaborative efforts at Glycozym Aps reinforce the importance of innovation in developing therapeutic solutions that can benefit society at large. As research in this area evolves, Detlef's contributions will undoubtedly play a vital role in shaping the future of medicinal applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…